Keep up to date with the latest technological developments happening across the Pharmaceutical industry. Our press releases can help you boost your online reach and exposure worldwide. Our Press releases provides information on the latest research in pharma.
Akari Therapeutics Plc a biopharmaceutical company focused on innovative therapeutics to treat orphan autoimmune and inflammatory diseases where the complement C andor leukotriene LTB systems are implicated today announced that the US Food and Drug...
Novartis a global leader in neuroscience today announced positive results for ofatumumab OMB from the Phase III ASCLEPIOS I and II studies In both headtohead studies ofatumumab demonstrated superiority over Aubagio teriflunomide in patients with rela...
SpringWorks Therapeutics Inc a clinicalstage biopharmaceutical company focused on developing lifechanging medicines for patients with severe rare diseases and cancer today announced the US Food and Drug Administration FDA has granted Breakthrough The...
PhillipsMedisize a Molex company announces a significant exhibiting and speaking presence at the Suzhou Dialogue conference organized by the China National Pharmaceutical Packaging Association CNPAA and to be held from September to in Suzhou Industr...
SHINKEI Therapeutics a clinical stage pharmaceutical company focused on the development of therapeutic drugs for the treatment of Central Nervous System CNS disorders today announced that they received notification from Food and Drug Administration F...
Esco Ventures is pleased to announce the launch of Carmine Therapeutics and execution of an exclusive license agreement for the technology developed in the laboratories of Professors Minh Le and Jiahai Shi at the City University of Hong Kong Carmine...
Adaptimmune Therapeutics plc a leader in Tcell therapy to treat cancer and NoileImmune Biotech Inc Tokyo Japan a biotechnology company focusing on the development of innovative cancer immunotherapies today announced that they will codevelop nextgener...
Sigilon Therapeutics today announced it has received Orphan Drug Designation for SIG an investigational therapy for hemophilia A that leverages Sigilons Shielded Living Therapeutics platform to implant cells engineered to produce stable blood plasma...
Velabs Therapeutics specializing in the fast generation of functional therapeutic antibodies today announced that its cooperation with Chiome Bioscience Inc Tokyo will be deepened to jointly discover modulatory and functional antibodies for one of Ch...
Rentschler Fill Solutions GmbH a contract development and manufacturing organization CDMO and expert for aseptic filling and finishing of biopharmaceuticals received notification from the Austrian Agency for Health and Food Safety
